Abbisko Thera deepens R&D collaboration with Lilly

▤ Summary

Abbisko Therapeutics has expanded its research collaboration with Eli Lilly through a strategic research and license agreement. The two companies will work together on discovering and developing innovative medicines across multiple targets. Abbisko aims to use the deal to advance novel drug candidates with global potential. Lilly gains access to external innovation and a broader pipeline of therapeutic programs.

▦ Linked Companies